Actively Recruiting

Age: 18Years +
All Genders
NCT06960954

PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma

Led by Tanta University · Updated on 2025-05-07

116

Participants Needed

1

Research Sites

50 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this cross-sectional observational study is to evaluate the relation between Prothrombin induced by vitamin K absence II (PIVKA-II) and the presence of portal vein tumor thrombosis (PVTT) in hepatocellular carcinoma (HCC) patients. Researchers will compare PIVKA-II serum levels in HCC patients with PVTT and without PVTT. Participants will undergo history-taking, clinical examination, laboratory investigations, PIVKA-II serum level, Child-Pugh classification, Model for End-stage Liver Disease (MELD) score, BCLC staging, abdominal ultrasonography, and Triphasic CT abdomen with contrast or MRI to evaluate tumor site, size, number, and presence of PVTT (a filling defect in the portal vein or its branch to distinguish PVTT or thrombus).

CONDITIONS

Official Title

PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female patients older than 18 years
  • Confirmed diagnosis of hepatocellular carcinoma (HCC) with or without portal vein tumor thrombosis (PVTT) diagnosed by two imaging tests or one imaging test with elevated serum alpha fetoprotein or liver biopsy
Not Eligible

You will not qualify if you...

  • Prior locoregional therapy or liver transplantation
  • Use of vitamin K, vitamin K antagonists, or antibiotics
  • Presence of cholestasis
  • Renal insufficiency
  • Other malignancies
  • Unwillingness to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tanta University Hospitals

Tanta, Gharbyea, Egypt, 31516

Actively Recruiting

Loading map...

Research Team

R

Rania M Elkafoury, MD

CONTACT

N

Nabila A Elgazzar, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here